International Randomized Study to Evaluate the Addition of Docetaxel (Taxotere) to the Combination of Cisplatin-5-Fluorouracil (TCF) vs. Cisplatin-5-Fluorouracil (CF) in the Induction Treatment of Nasopharyngeal Carcinoma (NPC) in Children and Adolescents

Trial Profile

International Randomized Study to Evaluate the Addition of Docetaxel (Taxotere) to the Combination of Cisplatin-5-Fluorouracil (TCF) vs. Cisplatin-5-Fluorouracil (CF) in the Induction Treatment of Nasopharyngeal Carcinoma (NPC) in Children and Adolescents

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
  • Indications Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 27 Jan 2012 Actual end date ( Jan 2012) added as reported by ClinicalTrials.gov.
    • 27 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2009 Planned end date changed from 1 Sep 2012 to 1 May 2012 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top